Page last updated: 2024-12-07

tingenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tingenone is a natural product isolated from the roots of *Tephrosia vogelii*. It is a potent inhibitor of the enzyme tyrosinase, which is involved in the production of melanin. Tingenone has been shown to have a variety of biological activities, including anti-inflammatory, antioxidant, and antimicrobial effects. It is being investigated for its potential therapeutic applications in the treatment of skin disorders, such as vitiligo and melasma, as well as for its potential to protect against UV-induced damage. Tingenone's synthesis involves a complex series of steps, starting from the natural product. It is studied because of its potential as a lead compound for the development of new drugs for various skin conditions.'

tingenone: quinonoid triterpene isolated from Euonymus tingens [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
EuonymusgenusA plant genus of the family CELASTRACEAE.[MeSH]CelastraceaeA plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida.[MeSH]
Euonymus tingensspecies[no description available]CelastraceaeA plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida.[MeSH]

Cross-References

ID SourceID
PubMed CID101520
SCHEMBL ID17064
MeSH IDM0054242

Synonyms (23)

Synonym
maytenin
tingenin a
NSC608781 ,
maitenin
tingenon
nsc-608781
maitenine
20-decarboxy-20-oxocelastrol
d:a-friedo-24,30-dinoroleana-1(10),3,5,7-tetraene-2,21-dione, 3-hydroxy-, (20-beta)-
50802-21-6
tingenone
(6as,6bs,8as,11r,12ar,14ar)-3-hydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione
nsc 608781
SCHEMBL17064
bdbm512755
acs.jmedchem.1c00409_st.349
DTXSID401318599
24,25,26,30-tetranoroleana-1(10),3,5,7-tetraene-2,21-dione, 3-hydroxy-9,13-dimethyl-, (9beta,13alpha,14beta,20beta)-
(9beta,13alpha,14beta,20beta)-3-hydroxy-9,13-dimethyl-24,25,26,30-tetranoroleana-1(10),3,5,7-tetraene-2,21-dione
R35Y6B78ZS
(6bs,8as,11r,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-2,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a-tetradecahydropicene-2,10-dione
tingenone iii
AKOS040746411
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)13.00000.00041.877310.0000AID356411
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusIC50 (µMol)9.90000.00402.92669.9600AID1805801; AID463921
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusKi4.00000.00753.00839.1100AID1805801; AID463922
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)9.90000.00022.45859.9600AID1805801
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2Ki4.00000.00001.63079.0000AID1805801
Tyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)IC50 (µMol)61.60000.31804.00429.6000AID551432
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (55)

Processvia Protein(s)Taxonomy
symbiont-mediated perturbation of host ubiquitin-like protein modificationReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
DNA damage checkpoint signalingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
triglyceride metabolic processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
epidermal growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
integrin-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
axonogenesisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
brain developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
heart developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
fibroblast growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
hormone-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytokine-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cerebellar cortex formationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
platelet formationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
T cell costimulationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of chondrocyte differentiationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of type I interferon productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
microvillus organizationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of interferon-beta productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of interleukin-6 productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of tumor necrosis factor productionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
multicellular organism growthTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
organ growthTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
megakaryocyte developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
atrioventricular canal developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
ERBB signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
hormone metabolic processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
glucose homeostasisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of protein-containing complex assemblyTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of ossificationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of mitotic cell cycleTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of glucose importTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of insulin secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of protein export from nucleusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of hormone secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
neurotrophin TRK receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
ephrin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
multicellular organismal reproductive processTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
genitalia developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
inner ear developmentTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
homeostasis of number of cells within a tissueTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of cortisol secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
Bergmann glial cell differentiationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
negative regulation of growth hormone secretionTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
face morphogenesisTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
intestinal epithelial cell migrationTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cellular response to epidermal growth factor stimulusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (26)

Processvia Protein(s)Taxonomy
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K63-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K48-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
phosphotyrosine residue bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
phosphoprotein phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
signaling receptor complex adaptor activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cell adhesion molecule bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
peptide hormone receptor bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
molecular adaptor activityTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cytoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (54)

Assay IDTitleYearJournalArticle
AID566855Cytotoxicity against human HL60 cells at 10 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID332902Cytotoxicity against human Lu1 cells after 72 hrs by sulforhodamine B assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID551432Inhibition of recombinant SHP22011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.
AID359903Cytotoxicity against mouse P388 cells by MTT assay1994Journal of natural products, Dec, Volume: 57, Issue:12
Cytotoxic aromatic triterpenes from Maytenus ilicifolia and Maytenus chuchuhuasca.
AID566854Cytotoxicity against human HL60 cells at 1 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID286232Antiprotozoal activity against Giardia intestinalis IMSS:0696:1 trophozoites after 48 hrs2007Journal of natural products, May, Volume: 70, Issue:5
Antigiardial activity of triterpenoids from root bark of Hippocratea excelsa.
AID332911Cytotoxicity against human Col2 cells after 96 hrs by sulforhodamine B assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID332910Cytotoxicity against human U373 cells after 96 hrs by sulforhodamine B assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID1100770Insecticidal activity against Cydia pomonella (codling moth) assessed as mortality at 20 mg/kg diet topically measured after 10 days of continuous exposure (Rvb = 3.3 +/- 3.3%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID566779Cytotoxicity against human HL60 cells after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID1100738Insecticidal activity against Cydia pomonella (codling moth) at 20 mg/kg assessed as growth regulation measured as number of head capsules of larvae after 5 days of continuous exposure (Rvb = 0.2 +/- 0.2%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID566857Cytotoxicity against human MCF7 cells at 1 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID332903Cytotoxicity against human SK-MEL-2 cells after 72 hrs by sulforhodamine B assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID357967DNA damaging activity against wild type DNA repairing RAD gene expressing yeast at 200 ug/mL by agar well diffusion assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Catalytic inhibition of topoisomerase IIalpha by demethylzeylasterone, a 6-oxophenolic triterpenoid from Kokoona zeylanica.
AID357966DNA damaging activity against topoisomerase 2-deficient rad52Y mutant yeast at 200 ug/mL by agar well diffusion assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Catalytic inhibition of topoisomerase IIalpha by demethylzeylasterone, a 6-oxophenolic triterpenoid from Kokoona zeylanica.
AID313987Growth inhibition of human RPMI8226 cells2008Bioorganic & medicinal chemistry letters, Feb-01, Volume: 18, Issue:3
Antimitotic quinoid triterpenes from Maytenus chuchuhuasca.
AID1100759Antifeedant activity against Cydia pomonella (codling moth) at 20 mg/kg diet topically measured after 5 days of continuous exposure (Rvb = 6.7 +/- 6.7%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID1100736Insecticidal activity against Cydia pomonella (codling moth) at 40 mg/kg assessed as growth regulation measured as number of head capsules of larvae after 5 days of continuous exposure (Rvb = 0.2 +/- 0.2%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID1100726Insecticidal activity against Cydia pomonella (codling moth) at 40 mg/kg assessed as growth regulation measured as number of head capsules of larvae after 10 days of continuous exposure Rvb = (1.5 +/- 0.2%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID1100769Insecticidal activity against Cydia pomonella (codling moth) assessed as mortality at 80 mg/kg diet topically measured after 10 days of continuous exposure (Rvb = 3.3 +/- 3.3%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID1100783Insecticidal activity against Cydia pomonella (codling moth) assessed as mortality at 20 mg/kg diet topically measured after 5 days of continuous exposure (Rvb = 0%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID566858Cytotoxicity against human MCF7 cells at 10 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID332901Cytotoxicity against human HT1080 cells after 48 hrs by sulforhodamine B assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID332908Cytotoxicity against human LNCAP cells after 72 hrs by sulforhodamine B assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID332904Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID1100724Insecticidal activity against Cydia pomonella (codling moth) at 80 mg/kg assessed as growth regulation measured as number of head capsules of larvae after 10 days of continuous exposure Rvb = (1.5 +/- 0.2%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID1100725Insecticidal activity against Cydia pomonella (codling moth) at 20 mg/kg assessed as growth regulation measured as number of head capsules of larvae after 10 days of continuous exposure Rvb = (1.5 +/- 0.2%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID332900Cytotoxicity against human BC1 cells after 72 hrs by sulforhodamine B assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID1100757Antifeedant activity against Cydia pomonella (codling moth) at 80 mg/kg diet topically measured after 5 days of continuous exposure (Rvb = 6.7 +/- 6.7%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID1100771Insecticidal activity against Cydia pomonella (codling moth) assessed as mortality at 40 mg/kg diet topically measured after 10 days of continuous exposure (Rvb = 3.3 +/- 3.3%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID1100734Insecticidal activity against Cydia pomonella (codling moth) at 80 mg/kg assessed as growth regulation measured as number of head capsules of larvae after 5 days of continuous exposure (Rvb = 0.2 +/- 0.2%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID359902Cytotoxicity against mouse L1210 cells by MTT assay1994Journal of natural products, Dec, Volume: 57, Issue:12
Cytotoxic aromatic triterpenes from Maytenus ilicifolia and Maytenus chuchuhuasca.
AID1100747Antifeedant activity against Cydia pomonella (codling moth) at 40 mg/kg diet topically measured after 10 days of continuous exposure (Rvb = 6.7 +/- 6.7%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID332909Cytotoxicity against human ZR-75-1 cells after 72 hrs by sulforhodamine B assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID1100758Antifeedant activity against Cydia pomonella (codling moth) at 40 mg/kg diet topically measured after 5 days of continuous exposure (Rvb = 6.7 +/- 6.7%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID357968DNA damaging activity against topoisomerase 2-deficient RS321N mutant yeast assessed as drug level required to produce 12 mm zone of inhibition by agar well diffusion assay2001Journal of natural products, Oct, Volume: 64, Issue:10
Catalytic inhibition of topoisomerase IIalpha by demethylzeylasterone, a 6-oxophenolic triterpenoid from Kokoona zeylanica.
AID1100782Insecticidal activity against Cydia pomonella (codling moth) assessed as mortality at 40 mg/kg diet topically measured after 5 days of continuous exposure (Rvb = 0%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID463922Inhibition of 3C-like protease of SARS coronavirus assessed as concentration of FRET peptide for 60 mins by dixon plot2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii.
AID566856Cytotoxicity against human HL60 cells at 30 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID566859Cytotoxicity against human MCF7 cells at 30 uM after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID566853Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Cytotoxic triterpenoids from Maytenus retusa.
AID1100746Antifeedant activity against Cydia pomonella (codling moth) at 80 mg/kg diet topically measured after 10 days of continuous exposure (Rvb = 6.7 +/- 6.7%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID332899Cytotoxicity against mouse P388 cells after 48 hrs by sulforhodamine B assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID90824Inhibitory activity against LPS-stimulated 1L-1beta release by cultured human monocytes1998Bioorganic & medicinal chemistry letters, Jul-21, Volume: 8, Issue:14
Novel cytokine release inhibitors. Part I: Triterpenes.
AID359904Cytotoxicity against human KB cells by MTT assay1994Journal of natural products, Dec, Volume: 57, Issue:12
Cytotoxic aromatic triterpenes from Maytenus ilicifolia and Maytenus chuchuhuasca.
AID332907Cytotoxicity against human A431 cells after 72 hrs by sulforhodamine B assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID332906Cytotoxicity against human KBV1 cells after 72 hrs by sulforhodamine B assay in absence of vinblastine1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID463921Inhibition of 3C-like protease of SARS coronavirus assessed as concentration of FRET peptide for 60 mins2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii.
AID1100780Insecticidal activity against Cydia pomonella (codling moth) assessed as mortality at 80 mg/kg diet topically measured after 5 days of continuous exposure (Rvb = 0%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID332905Cytotoxicity against human KBV1 cells after 72 hrs by sulforhodamine B assay in presence of vinblastine1994Journal of natural products, Jan, Volume: 57, Issue:1
Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea.
AID1100748Antifeedant activity against Cydia pomonella (codling moth) at 20 mg/kg diet topically measured after 10 days of continuous exposure (Rvb = 6.7 +/- 6.7%)2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae).
AID356411Inhibition of aldose reductase in rat lens homogenate2003Journal of natural products, Sep, Volume: 66, Issue:9
Structures of new friedelane-type triterpenes and eudesmane-type sesquiterpene and aldose reductase inhibitors from Salacia chinensis.
AID313986Inhibition of tubulin polymerization2008Bioorganic & medicinal chemistry letters, Feb-01, Volume: 18, Issue:3
Antimitotic quinoid triterpenes from Maytenus chuchuhuasca.
AID1805801Various Assay from Article 10.1021/acs.jmedchem.1c00409: \\Perspectives on SARS-CoV-2 Main Protease Inhibitors.\\2021Journal of medicinal chemistry, 12-09, Volume: 64, Issue:23
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (14.81)18.7374
1990's7 (25.93)18.2507
2000's6 (22.22)29.6817
2010's5 (18.52)24.3611
2020's5 (18.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.68 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]